CHARACTERIZATION OF 24-H CORTISOL RELEASE IN OBESE AND NONOBESE HYPERANDROGENIC WOMEN

被引:8
作者
MILLER, JE [1 ]
BRAY, MA [1 ]
FAIMAN, C [1 ]
REYES, FI [1 ]
机构
[1] SUNY HLTH SCI CTR,DIV REPROD ENDOCRINOL,BROOKLYN,NY
关键词
HYPERANDROGENISM; POLYCYSTIC OVARY DISEASE; CORTISOL SECRETION; OBESITY;
D O I
10.3109/09513599409023628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Excessive androgen output is a well-recognized feature of adrenocortical oversecretion in women with ovarian hyperandrogenism or polycystic ovary disease (PCOD). However, evidence of a concomitant alteration of cortisol secretion is lacking even though obesity per se, a common clinical feature of PCOD, has been shown to be associated with cortisol oversecretion. To clarify whether a subtle alteration in cortisol secretion exists, a study of 24-h episodic cortisol release and post-prandial cortisol responses was undertaken in eight women with PCOD and eight normal women comprising equal numbers of obese and non-obese subjects. All four groups showed normal biphasic 24-h cortisol secretion profiles but cortisol pulse frequency was increased in the PCOD groups. Independently, both hyperandrogenism and obesity were associated with an accelerated cortisol clearance rate. These changes, together with normal or only slightly elevated 24-h cortisol integrated area under the curve, suggest an increased compensatory cortisol production in women with PCOD. Furthermore, subjects with PCOD and subjects with obesity showed different post-prandial cortisol responses to normal non-obese women. In conclusion, these subtle cortisol abnormalities may be a manifestation of altered central regulation of the hypothalamic-pituitary-adrenal axis and peripheral metabolic abnormalities, and may be linked to the pathophysiology of PCOD.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 28 条
[1]  
Goldzieher J.W., Polycystic ovarian disease, Fertil. Steril., 35, pp. 371-394, (1981)
[2]  
Hoffman D.I., Klove K., Lobo R.A., The prevalence and significance of elevated dehy-droepiandrosterone sulfate levels in anovulatory women, Fertil. Steril., 42, pp. 76-81, (1984)
[3]  
Turner E.L., Watson M.J., Perry L.A., White M.C., Investigation of adrenal function in women with oligomenorrhea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test, Clin. Endocrinol., 36, pp. 389-397, (1992)
[4]  
Lachelin G.C.L., Barnett M., Hopper B.R., Brink G., Yen S.S.C., Adrenal function in normal women and women with the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 49, pp. 892-898, (1979)
[5]  
Rittmeister R.S., Thompson D.L., Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism, J. Clin. Endocrinol. Metab., 70, pp. 1096-1102, (1990)
[6]  
Carmina E., Lobo R.A., Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in hyper-androgenic patients, Gynecol. Endocrinol., 4, pp. 225-232, (1990)
[7]  
Streeten D.H.P., Stevenson C.T., Dalakos T.G., Nicholas J.J., Dennick I.G., Feller-Man H., The diagnosis of hypercortisolism: biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives, J. Clin. Endocrinol. Metab., 29, pp. 1191-1211, (1969)
[8]  
Strain G.W., Zumoff B., Strain J.J., Levin J., Fukushima D.K., Cortisol production in obesity, Metabolism, 29, pp. 980-985, (1980)
[9]  
Marin P., Darin N., Amemiya T., Anderson B., Jem S., Bjorntrop P., Cortisol secretion in relation to body fat distribution in obese premenopausal women, Metabolism, 41, pp. 882-886, (1992)
[10]  
Bray A.G., Wurtman R.J., Wurtman J.J., Overweight is risking fate: definition, classification, prevalence and risks, Human Obesity, 499, pp. 14-28, (1987)